Cargando…

Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171106/ https://www.ncbi.nlm.nih.gov/pubmed/37180596 http://dx.doi.org/10.1093/ofid/ofad252

Ejemplares similares

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Disparities in COVID-19 Vaccine Booster Uptake in the USA: December 2021–February 2022
por: Gaffney, Adam, et al.
Publicado: (2022)

COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021
por: Hagan, Liesl M., et al.
Publicado: (2021)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
por: Petrie, Joshua G., et al.
Publicado: (2023)

Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
por: Wang, Xiaoxiao, et al.
Publicado: (2022)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Response to Comment: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations
por: Lewis, Nathaniel M, et al.
Publicado: (2023)

Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022
por: Robilotti, Elizabeth V., et al.
Publicado: (2022)

COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020 – April 2021
por: Giansante, Chiara, et al.
Publicado: (2021)

COVID-19 Vaccine Administration, by Race and Ethnicity — North Carolina, December 14, 2020–April 6, 2021
por: Wong, Charlene A., et al.
Publicado: (2021)

461. COVID-19 Hospitalizations among Vaccinated and Unvaccinated Immunocompromised Children, 23 States, December 2022 – April 2023
por: Campbell, Angela P, et al.
Publicado: (2023)

Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022
por: Agaku, Israel T., et al.
Publicado: (2022)

Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022
por: Bajema, Kristina L., et al.
Publicado: (2023)

Timely Monitoring COVID-19 Vaccine Protection, Berlin, Germany, April 15th to December 15th, 2021
por: Bitzegeio, Julia, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021
por: Nickel, Katelin B., et al.
Publicado: (2022)

Marked Disparities in COVID-19 Vaccination among US Children and Adolescents by Racial/Ethnic, Socioeconomic, Geographic, and Health Characteristics, United States, December 2021 – April 2022
por: Singh, Gopal K., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023
por: Ciesla, Allison Avrich, et al.
Publicado: (2023)

PRAC meeting highlights April 2022: no link between mRNA COVID-19 vaccines and autoimmune hepatitis
Publicado: (2022)

Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers
por: Wi, Yu-Mi, et al.
Publicado: (2021)

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
por: Sinclair, Alyssa H., et al.
Publicado: (2023)

High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020
por: Hammer, Charlotte C., et al.
Publicado: (2021)

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021
por: Murthy, Bhavini Patel, et al.
Publicado: (2021)

Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April to August, 2021
por: Nguyen, Kimberly H., et al.
Publicado: (2022)

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023)

Severity of COVID-19–Related Illness in Massachusetts, July 2021 to December 2022
por: Azhir, Alaleh, et al.
Publicado: (2023)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Multifacility outbreak of Candida auris during the COVID-19 pandemic—Maricopa County, Arizona, April 2022–December 2022
por: Prasai, Siru, et al.
Publicado: (2023)

Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination
por: Sanchez Tijmes, Felipe, et al.
Publicado: (2022)

No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
por: Stevens, Natalie E., et al.
Publicado: (2023)

Suicide rates during the COVID-19 pandemic in Japan from April 2020 to December 2021
por: Nakanishi, Miharu, et al.
Publicado: (2022)

Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years — United States, August 13, 2021–August 5, 2022
por: Fast, Hannah E., et al.
Publicado: (2022)

High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020–Corrigendum
por: Hammer, Harlotte C., et al.
Publicado: (2021)

Update on: high but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020
por: Hammer, Charlotte C., et al.
Publicado: (2021)

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022
por: Johnson, Amelia G., et al.
Publicado: (2023)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ttni2bh0url1hm73haqq4md9p9